Showing results (21-30 of 294) with videos related to
Sort By:
Pageof 30
Journal of Hepatology|November 9, 2017
The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver diseaseMarie Boyle, Steven Masson, Quentin M AnsteeCell Cycle (Georgetown, Tex.)|March 15, 2014
Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver diseaseAloysious Aravinthan, George Mells, Michael Allison, et al.Current Pharmaceutical Design|February 12, 2013
Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatmentPaola Dongiovanni, Quentin M Anstee, Luca ValentiJournal of Hepatology|May 19, 2022
Impact of non-invasive biomarkers on hepatology practice: Past, present and futureQuentin M Anstee, Laurent Castera, Rohit LoombaFrontline Gastroenterology|July 15, 2014
Non-alcoholic fatty liver disease: a practical approach to diagnosis and stagingJessica K Dyson, Quentin M Anstee, Stuart McPhersonCell Metabolism|April 12, 2024
New and emerging treatments for metabolic dysfunction-associated steatohepatitisMonica A Tincopa, Quentin M Anstee, Rohit LoombaClinics and Research in Hepatology and Gastroenterology|May 17, 2011
The role of hypercoagulability in liver fibrogenesisQuentin M Anstee, Ameet Dhar, Mark R ThurszJournal of Hepatocellular Carcinoma|April 15, 2021
NAFLD-Associated HCC: Progress and OpportunitiesDaniel Geh, Quentin M Anstee, Helen L ReevesNature Reviews. Gastroenterology & Hepatology|May 2, 2018
Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver diseaseQuentin M Anstee, Alessandro Mantovani, Herbert Tilg, et al.Journal of Hepatology|July 16, 2011
The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studiesAhmad Al-Serri, Quentin M Anstee, Luca Valenti, et al.Pageof 30